SHOICHIMARUYAMA NagoyaJapan

• Linking Renal Pathology to Kidney Function
  Jonathan Barratt Speaker jb81@leicester.ac.ukUnited Kingdom
• Management of C3 Glomerulopathy: From Diagnosis to Targeted Therapy
  SHOICHIMARUYAMA Speaker marus@med.nagoya-u.ac.jpJapan
• Update on the Cardio-Kidney Metabolic Syndrome
  SolaAoun Bahous Speaker sola.bahous@gmail.comLebanon
• Q&A Session

• How Do I Manage Hepatorenal Syndrome?
  Lori-AnnFisher Speaker lori2k15@gmail.comJamaica
• How Do I Manage: Checkpoint Inhibitor-associated AKI
  MitchellRosner Speaker MHR9R@hscmail.mcc.virginia.eduUnited States
• Q&A Session

• A Snapshot of aHUS
  SHOICHIMARUYAMA Speaker marus@med.nagoya-u.ac.jpJapan
• The aHUS Clinical Picture
  AnujaJava Speaker ajava@wustl.eduUnited States
• Highlighting AHUS Associated With Triggers
  WaiLim Speaker wai.lim@health.wa.gov.auAustralia
• Q&A

• Chair's welcome
  SHOICHIMARUYAMA Moderator marus@med.nagoya-u.ac.jpJapan
• Evolution of C3G and primary IC-MPGN disease understanding: from molecular mechanisms to addressing patient needs
  EdwinWong Speaker edwin.wong1@nhs.netUnited Kingdom
• A race against time: the value of an early and accurate diagnosis
  Seung HyeokHan Speaker hansh@yuhs.acSouth Korea
• Panel discussion: Looking to the future: time to support our patients
  SHOICHIMARUYAMA Moderator. marus@med.nagoya-u.ac.jpJapan
• Q&A and close
  SHOICHIMARUYAMA Moderator. marus@med.nagoya-u.ac.jpJapan

• The Future of Lupus Nephritis: Achieving Renal Protection Through Proteinuria Control
  SHOICHIMARUYAMA Speaker marus@med.nagoya-u.ac.jpJapan
• A New Era in Lupus Nephritis: Clinical Evidence and Therapeutic Positioning of Triple Therapy
  KeijuHiromura Speaker hiomura@gunma-u.ac.jpJapan